Key facts
- BrioHealth Solutions’s last known valuation is $144.7M (Jun 2019).
- It has raised $100.0M; the latest was IPO in Dec 2025.
- Notable investors include HSG (Hong Kong), CICC Capital, Highlight Capital, China Growth Capital, BlackPine Group — 20 tracked in total.
- Status: In IPO Registration.
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for BrioHealth Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for BrioHealth Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BrioHealth Solutions
Manufacturer of ventricular assist devices VADs aims to transform heart failure treatment with advanced artificial heart technologies. The company develops VAD with high reliability, excellent hemocompatibility and a decreased rate of adverse events, helping clinicians and patients benefit from improved blood compatibility, infection control, and device longevity, enabling broader global access to high-end heart failure solutions.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2008
- Employees
- 86
- Website
- briohealthtech.com/
- Ownership
- In IPO Registration
BrioHealth Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrioHealth Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrioHealth Solutions in its N-PORT filings yet. We sweep new filings monthly.